Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV004024126 | SCV000647555 | likely benign | Familial adenomatous polyposis 1 | 2024-04-22 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000573552 | SCV000675889 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Color Diagnostics, |
RCV000573552 | SCV001347695 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-03 | criteria provided, single submitter | clinical testing | |
| Myriad Genetics, |
RCV004024126 | SCV004931231 | benign | Familial adenomatous polyposis 1 | 2024-03-28 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |